Delivery Order SPE2DB20D3103-SPE2DB23FN2Y7
Award Date 5/4/23
Potential Completion Date 5/5/23
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,944.85 firm-fixed-price delivery order is for the supply of 4,564,339,465 units of Bupropion HCL XL 150 mg tablets, with a completion date of April 22, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,732.67 firm-fixed-price delivery order is for the supply of 4,562,816,824 units of Bupropion HCL XL 150 mg tablets. The award has an ultimate completion date of November 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,368.94 firm fixed-price delivery order covers the supply of 4563862693 bupropion HCL XL 150 mg tablets to support military healthcare programs. The contract has a period of performance through March 6, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $1,583.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for Bupropion HCL XL 300 mg Tablets, with an ultimate completion date of November 13, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, with no major subcontractors...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award is for the delivery of Bupropion HCL XL 150 mg tablets in 500-count size, with a ceiling value of $10,602.74 and a period of performance through March 22, 2024. The contract is a firm fixed price delivery order, with no set-aside designation used....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an award value of $1,696.85 and is for the delivery of BUPROPION HCL XL 150 MG TABLET 90S, a generic pharmaceutical product. The contract has an ultimate completion date of April 27, 2023 and is structured as a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp has a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,133,134 units of Bupropion HCL XL 150 mg tablets. The contract has a ceiling value of $42,999.30 and a performance period through April 2, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,981,495 units of Bupropion HCl XL 300 mg tablets. The $3,363.79 contract has a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $31,648.98 firm fixed price delivery order is for the provision of 4564159083 - BUPROPION HCL XL 300 MG TABLET 500S. The award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was previously awarded to Amerisourcebergen...